Piśmiennictwo

1. Berlim MT, Van den Eynde F, Daskalakis ZJ. Efficacy and Acceptability of high frequency repetitive transcranial magnetic stimulation (rTMS) versus electroconvulsive therapy (ECT) for major depression: a systematic review and meta-analysis of randomized trials. Depression and Anxiety 2013;00:1-10

2. Gaynes BN, Warden D, Trivedi MH, Wisniewski SR, Fava M, Rush AJ. What did STAR*D Teach Us? Results from a large-scale, practical, clinical trial for patients with depression. Psychiatric Services 2009;60:1439-1445

3. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report. Am J Psychiatry 2006; 163:1905-1917

4. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. The Lancet 1985;1(8437):1106-7

5. Fitzgerald PB, Fountain S, Daskalakis ZJ. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin Neurophysiol 2006;117:2584-2596

6. Siebner HR, Rothwell J. Transcranial magnetic stimulation: new insights into representational cortical plasticity. Exp Brain Res. 2003;148(1):1-16

7. George MS, Post RM. Daily left prefrontal repetitive transcranial magnetic stimulation for acute treatment of medication-resistant depression. Am J Psychiatry 2011;168(4):356-364

8. Höflich G, Kasper S, Hufnagel A, Ruhrmann S, Möller HJ. Application of transcranial magnetic stimulation in treatment of drug-resistant major depression – a report of two cases. Human Psychopharmacology 1993;8:361-365

9. George MS, Wassermann EM, Williams WA, Callahan A, Ketter TA, Basser P i wsp. Daily repetitive transcranial magnetic stimulation (rTMS) improves mood in depression. Neuroreport 1995;6(14):1853-1856

10. George MS, Ketter TA, Post RM. Prefrontal cortex dysfunction in clinical depression. Depression 1994;2(2):59-72

11. George MS, Joseph JT, Baron Short E. The expanding evidence base for rTMS treatment of depression. Curr Opin Psychiatry 2013;26:13-18

12. Teneback CC, Nahas Z, Speer AM i wsp. Two weeks of daily left prefrontal rTMS changes prefrontal cortex and paralimbic activity in depression. J Neuropsychiatry Clin Neurosci 1999;11:426-435

13. Wang HN, Wang L, Zhang RG, Chen YC, Liu L i wsp. Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: the role of the endocannabinoid system. J Psychiatr Res. 2014;51:79-87

14. Zanardini R, Gazzoli A, Ventriglia M, Perez J, Bignotti S, Rossini PM i wsp. Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J Affect Disord. 2006;91(1):83-6.

15. Baeken C, De Raedt R, Bossuyt A, Van Hove C, Mertens J i wsp. The impact of HF-rTMS treatment on serotonin(2A) receptors in unipolar melancholic depression. Brain Stimul. 2011;4(2):104-11.

16. Strafella AP, Paus T, Fraraccio M, Dagher A. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex. Brain 2003;126:2609-2615.

17. Pogarell O, Koch W, Popperl G i wsp. Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study. J Psychiatr Res 2006;40(4):307-14

18. Luborzewski A, Schubert F, Seifert F, Danker-Hopfe H, Brakemeier EL i wsp. Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res. 2007;41(7):606-15

19. Bajbouj M, Luborzewski A, Hopfe-Danker H, Lang UE. Motor cortical excitability in depressive patients after electroconvulsive therapy and repetitive transcranial magnetic stimulation. J ECT 2005;21:243-245

20. Pridmore S. Rapid transcranial magnetic stimulation and normalization of the dexamethasone supression test. Psychiatry Clin Neurosci 1999;53(1):33-7

21. O’Reardon JP, Solvason Brent H, Janicak PG, Sampson Sh, Isenberg KE, Nahas Z i wsp. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007;62:1208-1216

22. George MS, Lisanby SH, Avery D, McDonald WM, Durkalski V, Pavlicova M i wsp. Daily Left Prefrontal Transcranial Magnetic Stimulation Therapy for Major Depressive Disorder. Arch Gen Psychiatry 2010;67(5):507-516

23. McDonald WM, Durkalski V, Ball ER, Holtzheimer PE, Pavlicova M, Lisanby SH i wsp. Improving the antidepressant efficacy of transcranial magnetic stimulation: maximizing the number of stimulations and treatment localization in treatment resistant depression. Depression and Anxiety 2011;28:973-980

24. Rush AJ, Trivedi MH, Wisniewski SR, Nierenberg AA, Stewart JW, Warden D i wsp. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006;163:1905-1917

25. Carpenter LL, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA i wsp. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety 2012;29:587-596

26. Connolly KR, Helmer A, Cristancho MA, Cristancho P, O’Reardon JP. Effectiveness of Transcranial Magnetic Stimulation in Clinical Practice Post-FDA Approval in the United States: Results Observed with the First 100 Consecutive Cases of Depression at an Academic Medical Center. J Clin Psychiatry 2012;73(4):e567-e573

27. Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM i wsp. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stmul 2010;3:187-199

28. Berlim MT, Van den Eynde F, Daskalakis ZJ. Clinically meaningful efficacy and acceptability of low-frequency repetitive transcranial magnetic stimulation (rTMS) for treating primary major depression: a meta-analysis of randomized, double-blind and sham-controlled trials. Neuropsychopharmacology 2013;38:543-551

29. Dolberg OT, Dannon PN, Schreiber S, Grunhaus L. Transcranial magnetic stimulation in patients with bipolar depression: a double blind, controlled study. Bipolar Disord 2002;2 (Suppl. 1):94-95

30. Nahas Z, Kozel FA, Li X, Anderson B, George MS. Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy. Bipolar Disord 2003;5:40-47

31. Tamas RL, Menkes D, El-Mallakh RS. Stimulating Research: a Prospective, Randomised, Double-Blind, Sham-Controlled Study of Slow Transcranial Magnetic Stimulation in Depressed Bipolar Patients. J Neuropsychiatry Clin Neurosci 2007;19:198-199

32. Dell‘Osso B, Mundo E, D‘Urso N, Pozzoli S, Buoli M, Ciabatti M i wsp. Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression. Bipolar Disorders 2009;11:76-81

33. Zyss T, Zięba A, Dudek D, Datka W, Siwek M, Wróbel A i wsp. Badania drugiej fazy nad skutecznością i bezpieczeństwem długotrwałej powtarzalnej szybkoczęstotliwościowej przezczaszkowej stymulacji magnetycznej w terapii depresji. Acta Bio-Optica et Informatica Medica 4/2011, vol.17

34. Dell’Osso B, Camuri G., Castellano F, Vecchi V, Benedetti M i wsp. Meta-Review of Metanalytic Studies with Repetitive Transcranial Magnetic Stimulation (rTMS) for the Treatment of Major Depression. Clinical Practice and Epidemiology in Mental Health 2011;7:167-177

35. Wassermann EM. Report on risk and safety of repetitive transcranial magnetic stimulation (rTMS): suggested guidelines from International Workshop on Risk and Safety of rTMS (June 1996). Electroencephalogr Clin Neurophysiol 1997;108:1-16

36. Rossi S, Hallet M, Rossini P, Pascual-Leone A. Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009;120(12):2008-39

37. Sakkas P, Mihalopoulou P, Mourtzouhou P i wsp. Induction of mania by rTMS: report of two cases. Eur Psychiatry 2003;18:196-8

38. Fregni F, Otachi PT, Do Valle A, Boggio PS, Thut G i wsp. A randomized clinical trial of repetitive transcranial magnetic stimulation in patients with refractory epilepsy. Ann Neurol 2006;60:447-455

39. Loo CK, McFarquhar TF, Mitchell PB. A review of the safety of repetitive transcranial magnetic stimulation as a clinical treatment for depression. Int J Neuropsychopharmacol 2008;11:131-147

40. Nadeau SE, Bowers D, Jones TL, Wu SS, Triggs WJ i wsp.Cognitive effects of treatment of depression with repetitive transcranial magnetic stimulation. Cognitive Behav Neurol 2014;27:77-87

41. Janicak PG, O’Reardon JP, Sampson SM, Husain MM, Lisanby SH i wsp. Transcranial magnetic stimulation in the treatment of major depressive disorder: a comprehensive summary ofsafety experience from acute exposure, extended exposure, and during reintroduction treatment. J Clin Psychiatry 2008;69(2):222-32

42. Fitzgerald PB, Hoy K, Gunewardene R, Slack C, Ibrahim S, Bailey M i wsp. A randomized trial of unilateral and bilateral prefrontal cortex transcranial magnetic stimulation in treatment-resistant major depression. Psychological Medicine 2011;41:1187-96

43. Holtzheimer PE, McDonald WM, Mufti M, Kelley ME, Quinn S, Corso G i wsp. Accelerated repetitive transcranial magnetic stimulation for treatment-resistant depression. Depression and Anxiety 2010;27:960-963

44. Hadley D, Anderson BS, Borckardt JJ, Aschley A, Xingbao L i wsp. Safety, tolerability and effectiveness of high doses of adjunctive daily left prefrontal repetitive transcranial magnetic stimulation for treatment-resistant depression in a clinical setting. Journal of ECT 2011;27:18-25

45. McDonald WM, Durkalski V, Ball ER, Holtzheimer III MD, Pavlicova M i wsp. Improving the antidepressant efficacy of transcranial magnetic stimualation: maximizing the number of stimulations and treatment location in treatment-resistant depression. Depression and Anxiety 2011;28:973-980

46. Bersani FS, Minichino A, Enticott PG, Mazzarini L, Khan N, Antonacci G i wsp. Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: A comprehensive review. Eur Psychiatry 2013;28(1):30-9

47. Downar J, Daskalakis ZJ. New targets for rTMS in depression: A review of convergent evidence. Brain Stimul 2013;6 (3):231-240

48. Salomons TV, Dunlop K, Kennedy SH, Flint A, Geraci J, Giacobbe P i wsp. Resting-State Cortico-Thalamic-Striatal Connectivity Predicts Response to Dorsomedial Prefrontal rTMS in Major Depressive Disorder. Neuropsychopharmacology 2014;39(2):488-98

49. Jin Y, Phillips B. A pilot study of the use of EEG-based synchronized Transcranial Magnetic Stimulation (sTMS) for treatment of Major Depression. BMC Psychiatry 2014;14:13

50. Christyakov AV, Rubicsek O, Kaplan B, Zaaroor M, Klein E. Safety, tolerability and preliminary evidence for antidepressant efficacy of theta-burst transcranial magnetic stimulation in patients with major depression. International Journal of Neuropsychopharmacology 2010;13:387-393

51. Plewnia Ch, Pasqualetti P, Grobe S, Schlipf S, Wasserka B i wsp. Treatment of major depression with bilateral theta burst stimulation: A randomized controlled pilot trial. Journal of Affective Disorders 2014;156:219-223

52. Arul-Anandam AP, Loo C. Transcranial direct current stimulation: a new tool for the treatment of depression? J Affect Disord. 2009;117 (3):137-45

53. Bindman LJ, Lippold OCJ, Redfearn JWT. The action of brief polarizing currents on the cerebral cortex of the rat (1) during current flow and (2) in the production of long lasting after effects. J. Physiol. 1964;172:369-382

54. Purpura DP, McMurry JG. Intracellular actvities and evoked potential changes during polarization of the motor cortex. J. Neurophysiol. 1965;28:166-185

55. Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J. Physiol. 2000;527:633-639

56. Tehovnik EJ. Electrical stimulation of neural tissue to evoke behavioral responses. J. Neurosci. Methods 1996;65:1-17

57. Wagner T, Fregni F, Fecteau S, Grodzinsky A, Zahn M, Pascual-Leone A. Transcranial direct current stimualation: a computer-based human model study. Neuroimage 2007;35:1113-1124

58. Nitsche MA, Fricke K, Henschke A, Schlitterlau D, Liebetanz N, Lang S, Henning F, Tergau F, Paulus W. Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans. J. Physiol. 2003;533:293-301

59. Nitsche MA, Jaussi W, Liebetanz D, Lang N, Tergau F, Paulus W. Consolidation of human motor cortex neuroplasticity by d-cycloserine. Neuropsychopharmacology 2004;29:1573-1578

60. Nitsche MA, Lampe C, Antal A, Liebetanz D, Lang N, Tergau F, Paulus W. Dopaminergic modulation of long-lasting direct current-induced cortical excitability changes in the human motor cortex. Eur. J. Neurosci. 2006;23:1651-1657

61. Nitsche MA, Kuo MF, Karrasch R, Wächter B, Liebetanz D, Paulus W. Serotonin affects transcranial direct current-induced neuroplasticity in humans. Biol Psychiatry 2009;66(5):503-8

62. Loo CK, Alonzo A, Martin D, Mitchell PB, Galvez V, Sachdev P. Transcranial direct current stimulation for depress: 3-week, randomised, sham-controlled trial. The British Journal of Psychiatry 2012;200:52-59

63. Brunoni AR, Valiengo L, Baccaro A, Zanão TA, de Oliveira JF i wsp. The sertraline vs Electrical Current Therapy for Treating Depression Clinical Study. Results from a factorial, randomized, controlled trial. JAMA Psychiatry 2013;70(4):383-391

64. Shiozawa P, Fregni F, Benseňor IM, Lotufo PA, Berlim MT i wsp. Transcranial direct current stimulation for major depression: an updated systematic review and metaanalysis. Int J Neuropsychopharmacol. 2014;8:1-10

65. Valiengo L, Benseňor IM, Goulart AC, Oliveira JF, Zanao TA. The sertraline versus electrical current therapy for treating depression clinical study (SELECT-TDCS): results of the crossover and follow-up phases. Depression and Anxiety 2013;00:1-8

66. Martin DM, Alonzo A, Ho KA, Player M, Mitchell PB. Continuation transcranial direct current stimulation for the prevention of relapse in major depression. J Affect Disord. 2013;44(3):274-8

67. Brunoni AR, Ferrucci R, Bortolomasi M, Vergari M, Tadini L i wsp. Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011;35(1):95-101

68. Brunoni AR, Boggio PS, De Raedt R, Benseňor IM, Lotufo PA i wsp. Cognitive control therapy and transcranial direct current stimulation for depression: A randomised, double-blinded, controlled trial. Journal of Affective Disorders 2014;162:43-49

69. Chan H-N, Alonzo A, Martin DM, Mitchell PB, Sachdev P i wsp. Augmenting Transcranial Direct Current Stimulation with D-cycloserine for Depression. A pilot study. Journal of ECT 2013;29:196-200

70. Fricke K, Seeber AA, Thirugnanasambandam N, Paulus W, Nitsche MA, Rothwell JC. Time course of the induction of homeostatic plasticity generated by repeated transcranial direct current stimulation of the human motor cortex. J Neurophysiol. 2011;105(3):1141-9

71. 1Alonzo A, Brassil J, Taylor JL, Martin D, Loo CK. Daily transcranial direct current stimulation (tDCS) leads to greater increases in cortical excitability than second daily transcranial direct current stimulation. Brain Stimul. 2012;5(3):208-13

72. Gálvez V, Alonzo A, Martin D, Loo CK. Transcranial direct current stimulation treatment protocols: should stimulus intensity be constant or incremental over multiple sessions? Int J Neuropsychopharmacol. 2013;16(1):13-21

73. Martin DM, Alonzo A, Mitchell PB, Sachdev P, Gálvez V, Loo CK. Fronto-extracephalic transcranial direct current stimulation as a treatment for major depression: an open – label pilot study. J Affect Disord. 2011;134(1-3):459-63